BVF Inc’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $120M | Buy |
960,989
+81,980
| +9% | +$8.55M | 3.82% | 8 |
|
|
2025
Q4 | $92M | Sell |
879,009
-282,240
| -24% | -$24.1M | 3.1% | 10 |
|
|
2025
Q3 | $72.8M | Buy |
1,161,249
+464,694
| +67% | +$20.7M | 2.95% | 12 |
|
|
2025
Q2 | $15.7M | Hold |
696,555
| – | – | 0.56% | 28 |
|
|
2025
Q1 | $19.5M | Hold |
696,555
| – | – | 0.79% | 25 |
|
|
2024
Q4 | $8.36M | Buy |
696,555
+438,929
| +170% | +$6.89M | 0.28% | 40 |
|
|
2024
Q3 | $4.31M | Hold |
257,626
| – | – | 0.13% | 44 |
|
|
2024
Q2 | $2.55M | Buy |
257,626
+3
| +0% | +$34 | 0.07% | 51 |
|
|
2024
Q1 | $3.78M | Hold |
257,623
| – | – | 0.1% | 53 |
|
|
2023
Q4 | $3.75M | Hold |
257,623
| – | – | 0.09% | 57 |
|
|
2023
Q3 | $6.14M | Hold |
257,623
| – | – | 0.17% | 52 |
|
|
2023
Q2 | $3.41M | Buy |
257,623
+194,119
| +306% | +$11.8M | 0.1% | 58 |
|
|
2023
Q1 | $4.96M | Hold |
63,504
| – | – | 0.18% | 58 |
|
|
2022
Q4 | $5.28M | Hold |
63,504
| – | – | 0.22% | 57 |
|
|
2022
Q3 | $5.84M | Hold |
63,504
| – | – | 0.24% | 58 |
|
|
2022
Q2 | $9.5M | Sell |
63,504
-3,099
| -5% | -$565K | 0.46% | 52 |
|
|
2022
Q1 | $16.1M | Hold |
66,603
| – | – | 0.65% | 40 |
|
|
2021
Q4 | $20.1M | Hold |
66,603
| – | – | 0.73% | 39 |
|
|
2021
Q3 | $27.5M | Hold |
66,603
| – | – | 1.07% | 25 |
|
|
2021
Q2 | $20.4M | Sell |
66,603
-2,079
| -3% | -$456K | 0.76% | 36 |
|
|
2021
Q1 | $14.1M | Hold |
68,682
| – | – | 0.53% | 40 |
|
|
2020
Q4 | $13.7M | Hold |
68,682
| – | – | 0.54% | 38 |
|
|
2020
Q3 | $11.4M | Buy |
68,682
+29,740
| +76% | +$6.77M | 0.62% | 42 |
|
|
2020
Q2 | $9.66M | Sell |
38,942
-34,468
| -47% | -$8.06M | 0.6% | 40 |
|
|
2020
Q1 | $13.4M | Buy |
73,410
+6,536
| +10% | +$1.65M | 1.25% | 25 |
|
|
2019
Q4 | $19.4M | Hold |
66,874
| – | – | 1.47% | 18 |
|
|
2019
Q3 | $18.2M | Buy |
66,874
+17,446
| +35% | +$6.75M | 1.92% | 17 |
|
|
2019
Q2 | $18.6M | Sell |
49,428
-1,302
| -3% | -$388K | 2.03% | 17 |
|
|
2019
Q1 | $13.6M | Sell |
50,730
-42,494
| -46% | -$10.1M | 1.52% | 23 |
|
|
2018
Q4 | $19.8M | Buy |
93,224
+23,217
| +33% | +$7.2M | 2.59% | 14 |
|
|
2018
Q3 | $31.4M | Buy |
70,007
+3,172
| +5% | +$1.38M | 2.76% | 12 |
|
|
2018
Q2 | $27.1M | Buy |
66,835
+21,928
| +49% | +$10.4M | 2.65% | 14 |
|
|
2018
Q1 | $24.5M | Buy |
44,907
+12,112
| +37% | +$7.5M | 2.48% | 15 |
|
|
2017
Q4 | $19.8M | Sell |
32,795
-4,537
| -12% | -$2.11M | 2.39% | 15 |
|
|
2017
Q3 | $17.2M | Sell |
37,332
-6,317
| -14% | -$2.7M | 2.19% | 17 |
|
|
2017
Q2 | $17.7M | Buy |
43,649
+19,686
| +82% | +$5.75M | 2.74% | 12 |
|
|
2017
Q1 | $4.98M | Buy |
23,963
+778
| +3% | +$138K | 0.85% | 26 |
|
|
2016
Q4 | $2.61M | Buy |
23,185
+10,478
| +82% | +$1.3M | 0.52% | 25 |
|
|
2016
Q3 | $1.86M | Buy |
12,707
+9,690
| +321% | +$1.29M | 0.35% | 27 |
|
|
2016
Q2 | $389K | Buy |
+3,017
| New | +$462K | 0.08% | 33 |
|
Other funds holding PVLA
SCM
FLAM
FLSM
VCM
FCM
BVF Inc's PVLA Position: Q1 2026 in Review
BVF Inc increased its Palvella Therapeutics (PVLA) stake by 9.3% in Q1 2026, buying an estimated $8.55M and bringing the position to 960,989 shares worth $120M. The position accounts for 3.82% of the portfolio, ranked #8.
BVF Inc first reported a position in PVLA in Q2 2016 and has held it in 40 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.
- BVF Inc held 960,989 shares of Palvella Therapeutics worth $120M as of Q1 2026.
- BVF Inc bought 81,980 Palvella Therapeutics shares in Q1 2026, an estimated $8.55M.
- Palvella Therapeutics made up 3.82% of BVF Inc's portfolio in Q1 2026, its #8 holding.
- BVF Inc first reported a position in Palvella Therapeutics in Q2 2016 and has held it in 40 quarters since.
- 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.
Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.